These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21176997)

  • 1. Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration.
    Ziebell M; Khalid U; Klein AB; Aznar S; Thomsen G; Jensen P; Knudsen GM
    Neurobiol Aging; 2012 Feb; 33(2):428.e1-5. PubMed ID: 21176997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
    Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
    Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
    Sossi V; de la Fuente-Fernández R; Schulzer M; Troiano AR; Ruth TJ; Stoessl AJ
    Ann Neurol; 2007 Nov; 62(5):468-74. PubMed ID: 17886297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
    Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.
    Bédard C; Wallman MJ; Pourcher E; Gould PV; Parent A; Parent M
    Parkinsonism Relat Disord; 2011 Sep; 17(8):593-8. PubMed ID: 21664855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice.
    Vuillermot S; Feldon J; Meyer U
    Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K; Jones SA; Hyman C; Zimmer J
    Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No correlation between body mass index and striatal dopamine transporter availability in healthy volunteers using SPECT and [123I]PE2I.
    Thomsen G; Ziebell M; Jensen PS; da Cuhna-Bang S; Knudsen GM; Pinborg LH
    Obesity (Silver Spring); 2013 Sep; 21(9):1803-6. PubMed ID: 23696269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
    Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
    Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
    Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
    Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling.
    Cilia R; Ko JH; Cho SS; van Eimeren T; Marotta G; Pellecchia G; Pezzoli G; Antonini A; Strafella AP
    Neurobiol Dis; 2010 Jul; 39(1):98-104. PubMed ID: 20338240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study.
    Braga-Neto P; Felicio AC; Hoexter MQ; Pedroso JL; Dutra LA; Alessi H; Minett T; Santos-Galduroz RF; da Rocha AJ; Garcia LA; Bertolucci PH; Bressan RA; Barsottini OG
    Parkinsonism Relat Disord; 2012 Aug; 18(7):854-8. PubMed ID: 22575233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
    Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
    Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.
    Seki C; Ito H; Ichimiya T; Arakawa R; Ikoma Y; Shidahara M; Maeda J; Takano A; Takahashi H; Kimura Y; Suzuki K; Kanno I; Suhara T
    Ann Nucl Med; 2010 May; 24(4):249-60. PubMed ID: 20364374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-guided region-of-interest delineation is comparable to manual delineation in dopamine transporter SPECT quantification in patients: a reproducibility study.
    Ziebell M; Pinborg LH; Thomsen G; de Nijs R; Svarer C; Wagner A; Knudsen GM
    J Nucl Med Technol; 2010 Jun; 38(2):61-8. PubMed ID: 20484180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.
    Costa A; Riedel M; Müller U; Möller HJ; Ettinger U
    Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson's disease.
    Honkanen EA; Saari L; Orte K; Gardberg M; Noponen T; Joutsa J; Kaasinen V
    Mov Disord; 2019 Oct; 34(10):1562-1566. PubMed ID: 31234224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies.
    Ziebell M; Andersen BB; Pinborg LH; Knudsen GM; Stokholm J; Thomsen G; Karlsborg M; Høgh P; Mørk ML; Hasselbalch SG
    J Nucl Med; 2013 Jul; 54(7):1072-6. PubMed ID: 23637201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.